Based on previous observations in vitro 4 and in vivo,8 we hypothesized that the enhancement of GR transcriptional activity by antihistamines could be used to reduce GC’s effective doses used to counteract asthma symptoms, possibly resulting in new (and safer) therapeutic strategies to treat asthma. The gene discussed is NR3C1; the disease is asthma.